Global Patent Index - EP 2891089 A2

EP 2891089 A2 20150708 - SAFEGUARDING TECHNIQUES FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM

Title (en)

SAFEGUARDING TECHNIQUES FOR A CLOSED-LOOP INSULIN INFUSION SYSTEM

Title (de)

SICHERHEITSVERFAHREN FÜR EIN GESCHLOSSENES INSULININFUSIONSSYSTEM

Title (fr)

TECHNIQUES DE SÉCURITÉ POUR SYSTÈME DE PERFUSION D'INSULINE EN BOUCLE FERMÉE

Publication

EP 2891089 A2 20150708 (EN)

Application

EP 13753741 A 20130814

Priority

  • US 201261694950 P 20120830
  • US 201261694961 P 20120830
  • US 201361812874 P 20130417
  • US 201313870902 A 20130425
  • US 201313870907 A 20130425
  • US 201313870910 A 20130425
  • US 201313966109 A 20130813
  • US 201313966101 A 20130813
  • US 201313966114 A 20130813
  • US 201313966120 A 20130813
  • US 2013054996 W 20130814

Abstract (en)

[origin: WO2014035672A2] Processor-implemented methods of controlling an insulin infusion device for a user are provided here. A first method obtains and analyzes calibration factors (and corresponding timestamp data) for a continuous glucose sensor, and regulates entry into a closed-loop operating mode of the infusion device based on the calibration factors and timestamp data. A second method obtains a most recent sensor glucose value and a target glucose setpoint value for the user at the outset of the closed-loop mode. The second method adjusts the closed-loop insulin infusion rate over time, in response to the sensor glucose value and the setpoint value. A third method calculates an upper insulin limit that applies to the insulin infusion rate during the closed-loop mode. The insulin limit is calculated based on a fasting blood glucose value of the user, a total daily insulin value of the user, and fasting insulin delivery data for the user.

IPC 8 full level

G06F 19/00 (2011.01)

CPC (source: EP KR US)

A61B 5/14532 (2013.01 - EP KR); A61B 5/1495 (2013.01 - EP KR); A61B 5/4839 (2013.01 - EP KR US); A61M 5/14248 (2013.01 - EP KR); A61M 5/1723 (2013.01 - EP KR); G16H 10/60 (2017.12 - EP US); G16H 20/17 (2017.12 - EP KR US); G16H 40/63 (2017.12 - EP KR US); G16H 50/20 (2017.12 - EP KR); A61M 2005/14208 (2013.01 - EP KR); A61M 2230/201 (2013.01 - EP KR)

Citation (search report)

See references of WO 2014035672A2

Citation (examination)

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2014035672 A2 20140306; WO 2014035672 A3 20140912; AU 2013309344 A1 20150226; AU 2013309344 B2 20181108; CA 2882300 A1 20140306; CA 2882300 C 20201229; CA 2884997 A1 20140306; CA 2884997 C 20200526; CA 2885003 A1 20140306; CA 2885003 C 20210622; CN 104769595 A 20150708; CN 104769595 B 20171208; CN 105046042 A 20151111; CN 105046042 B 20181009; CN 105169525 A 20151223; CN 105169525 B 20190402; EP 2891089 A2 20150708; EP 2897070 A1 20150722; EP 2897071 A1 20150722; EP 2897071 B1 20190522; JP 2015165970 A 20150924; JP 2015192889 A 20151105; JP 2015528348 A 20150928; JP 6039016 B2 20161207; JP 6073478 B2 20170201; KR 102054540 B1 20191210; KR 102147838 B1 20200826; KR 102147850 B1 20200826; KR 20150043534 A 20150422; KR 20150045522 A 20150428; KR 20150050563 A 20150508

DOCDB simple family (application)

US 2013054996 W 20130814; AU 2013309344 A 20130814; CA 2882300 A 20130814; CA 2884997 A 20130814; CA 2885003 A 20130814; CN 201380055567 A 20130814; CN 201510274455 A 20130814; CN 201510275978 A 20130814; EP 13753741 A 20130814; EP 15157701 A 20130814; EP 15157703 A 20130814; JP 2015130885 A 20150630; JP 2015130886 A 20150630; JP 2015529845 A 20130814; KR 20157006674 A 20130814; KR 20157008489 A 20130814; KR 20157008517 A 20130814